Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Nature Communications
|
August 2, 2024
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer
Sakina A Plumber, Tiffany Tate, Hikmat Al-Ahmadie, et al.
The Journal of Pathology
|
September 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer
Sangkyou Lee, Sung Yun Jung, Pawel Kuś, et al.
Scientific Reports
|
June 18, 2020
Assessment of Luminal and Basal Phenotypes in Bladder Cancer
Charles C Guo, Jolanta Bondaruk, Hui Yao, et al.
Cell Reports
|
February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis
Tadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
Cell Reports
|
April 27, 2024
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis
Sangkyou Lee, Jolanta Bondaruk, Yishan Wang, et al.
Scientific Reports
|
January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
Aaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience
|
July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Iscience
|
June 24, 2022
The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Iscience
|
June 11, 2020
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
Guoliang Yang, Jolanta Bondaruk, David Cogdell, et al.
Cell Reports
|
May 9, 2019
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
Charles C Guo, Tadeusz Majewski, Li Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Nature Communications
|
August 2, 2024
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer
Sakina A Plumber, Tiffany Tate, Hikmat Al-Ahmadie, et al.
The Journal of Pathology
|
September 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer
Sangkyou Lee, Sung Yun Jung, Pawel Kuś, et al.
Scientific Reports
|
June 18, 2020
Assessment of Luminal and Basal Phenotypes in Bladder Cancer
Charles C Guo, Jolanta Bondaruk, Hui Yao, et al.
Cell Reports
|
February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis
Tadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
Cell Reports
|
April 27, 2024
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis
Sangkyou Lee, Jolanta Bondaruk, Yishan Wang, et al.
Scientific Reports
|
January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
Aaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience
|
July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Iscience
|
June 24, 2022
The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Iscience
|
June 11, 2020
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
Guoliang Yang, Jolanta Bondaruk, David Cogdell, et al.
Cell Reports
|
May 9, 2019
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
Charles C Guo, Tadeusz Majewski, Li Zhang, et al.
Page
of 6